Our CRUK Convergence Science Centre 2022 Symposium was organised the 17th of January 2024 at the he Royal Geographical Society (London). The focal theme of our symposium "Engineering Cancer Research" was centred on the transformative impact of engineering in revolutionising both discovery and clinical research within the field of oncology. This event highlighted the vital role of engineering principles and design methodologies in advancing cancer research, maintaining a steadfast focus on patient-centric approaches. We explored how engineering can significantly alter traditional research paradigms, leading to more effective, bespoke, and compassionate patient care.
Enhancing EDI in Participatory Research: Elevating Participation and Methodology in Cancer Research and Engineering Innovations
Organisers: Dr Patrick Kierkegaard (CSC), Ms Kelly Gleason (Imperial), Dr Markella Boudioni (RMH)
Prof Axel Behrens (Scientific Director, CRUK Convergence Science Centre)
Professor Rylie Green – Head of the Bioengineering Department at Imperial College London
Professor Yan Yan Sheri Huang – CRUK Cambridge Centre, Department of Bioengineering, University of Cambridge
Kelly Gleason & Sonal Thakrar
Melanie Herpels
Joseph Broomfield
Professor Dow-Mu Koh – Co-Director AI imaging Hub at The Royal Marsden NIHR BRC
Professor Constantin Coussios – Director of the Oxford Institute of Biomedical Engineering, University of Oxford
Introduction by Prof the Lord Ara Darzi
Our CRUK Convergence Science Centre 2022 Symposium was organised the 7th of December 2022 at the Millennium Gloucester Hotel. On this occasion we also welcomed our local research community, research funding bodies and other major initiatives such as the NIHR Biomedical Research Centres and Experimental Cancer Medicine Centres to accelerate the translation of research for patient benefit.
Prof Axel Behrens (Scientific Director, CRUK Convergence Science Centre)
NIHR BRC Overview
Prof David Cunningham (Director, Marsden BRC)
Clinical Delivery: Forward and Reverse Translation
Prof Johann de Bono (Director of the Drug Development Unit, ICR)
Transforming Brain Cancer Resection with Real-Time, Multi-Scale Imaging
Drug Delivery to a Paediatric Tumour Model Using Short-pulse Focused Ultrasound and Microbubble Exposure
Dani Chatterton (Convergence Science Centre PhD Student)
Magnetic Resonance Fingerprinting for Brain Tumours
Imperial NIHR BRC Overview
Prof Iain McNeish (BRC Cancer theme lead and Head of Cancer Division, Imperial)
Dr Sam Au (Senior Lecturer, Dept. of Bioengineering, Imperial)
Unravelling the Tumour Microenvironment Using Convergence Science
Introduction by Prof Kristian Helin (CEO, ICR)
.jpg?sfvrsn=822ee52c_0)
